ITOS - Total Utang marang Modal iTeos Pharma
iTeos Therapeutics (ITOS) focuses on developing targeted oncology treatments by activating the body's own immune defenses. This chart for the stock on the GURU.Markets platform shows the total debt-to-equity metric as 0.01. Operations in the US and Belgium rely on partner support and successful trial outcomes, while the company strictly adheres to laboratory waste disposal protocols to minimize environmental impact.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ITOS_-_iTeos-Therapeutics_-_All-Debt-to-Shareholders-Equity-Ratio "ITOS (iTeos Therapeutics) riwayat Total Utang marang Modal saka 04.07.2022 nganti 14.09.2025 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan iTeos Therapeutics
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas iTeos Therapeutics|ITOS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal iTeos Therapeutics|ITOS - Gunggung utang perusahaan|Utang marang nilai buku iTeos Therapeutics|ITOS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan iTeos Therapeutics|Likuiditas cepet iteostherapeutics.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:iTeos Therapeutics, Inc.
Conservative capital requires transparency in financing structures to assess business resilience to rate volatility. This indicator measures the proportion of borrowed funds relative to equity, determining the level of financial risk and dependence on external creditors. For the biotech firm iTeos Therapeutics (ITOS), which invests in R&D and scientist retention through stock options, the company's debt leverage history demonstrates a balance between equity and debt obligations.
Analisis pesaing iTeos Therapeutics
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Savara Pharma SVRA|RIGL (Rigel Pharmaceuticals) - Rasio Total Utang marang Ekuitas|ANAB: Utang Agregat marang Modal|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal enGene Holdings Inc ENGN|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|JBIO - Utang marang Modal|Utang marang Ekuitas Aclaris Therapeutics ACRS|Koefisien Total Utang marang Modal kyvernatx.com (KYTX)|TLSA: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CABA (Cabaletta Bio Inc.)|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|THTX: Utang Agregat marang Modal|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|ELDN: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AGEN|CLYM - Utang marang Modal|Utang marang Ekuitas Zura Bio Limited ZURA|Rasio Kabeh Utang marang Dana Pribadi ATYR|Adagene Corp - Total Utang marang Modal|IMA - Total Utang marang Modal|shattucklabs.com (STTK) - Utang marang Ekuitas|Utang Agregat marang Ekuitas EQ (Equillium)|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Utang marang Modal Immunic Inc IMUX|Rasio Total Utang marang Ekuitas ATRA (Atara Biotherapeutics)|Total Utang marang Modal inflarx.de (IFRX)|X4 Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ACET (Adicet Bio Inc.)|Celularity Corp - Total Utang marang Modal|Koefisien Total Utang marang Modal INmune Bio Corporation INMB|BRNS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas kezarlifesciences.com|Utang marang Ekuitas SAB Biotherapeutics, Inc.|Akari Therapeutics PLC (AKTX) - Koefisien Total Utang marang Modal|Total Utang marang Modal ENLV|Koefisien Total Utang marang Modal q32bio.com|GeoVax Labs, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal EDSA (edesabiotech.com)|IBIO - Utang marang Ekuitas|Utang marang Modal Carisma Therapeutics|XTL Biopharmaceuticals, Ltd. (XTLB) - Utang marang Ekuitas|BOLT - Koefisien Total Utang marang Modal|Utang marang Ekuitas HCW Biologics, Inc.|Aptevo - Utang Agregat marang Ekuitas|Total Utang marang Modal AIM|ADTX (aditxt.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GRI (GRI Bio Corp)|Total Utang marang Modal XORTX Corp XRTX|HIND - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Total Utang marang Modal|Total Utang marang Modal Affimed Therapeutics|Rasio Total Utang marang Ekuitas ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IGMS (IGM Biosciences)|Koefisien Total Utang marang Modal Ocean Biomedical Inc (OCEA)|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas